Innovating for health

Biohit´s innovations prevent illnesses and improve quality of life

Start here

Are you an investor, a professional or a consumer?

Investor

Professional

Consumer

News & Events

How are monoclonal antibodies advancing modern research?

BIOHIT at the United European Gastroenterology Week (UEGW) 2025 in Berlin!

Join us at the Tampere Celiac Disease Symposium 2025 – Personalising Patient Care and Research

Company

Biohit Healthcare

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare.

Read our annual report ↗